Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
Hurkmans DP, Verdegaal EME, Hogan SA, de Wijn R, Hovestad L, van den Heuvel DMA, Ruijtenbeek R, Welters MJP, van Brakel M, Basak EA, Pinedo HM, Lamers CHJ, van de Werken HJG, Groten JP, Debets R, Levesque MP, Dummer R, Kapiteijn E, Mathijssen RHJ, Aerts JGJV, van der Burg SH.
Hurkmans DP, et al. Among authors: ruijtenbeek r.
J Immunother Cancer. 2020 Dec;8(2):e001607. doi: 10.1136/jitc-2020-001607.
J Immunother Cancer. 2020.
PMID: 33427690
Free PMC article.